Lido Advisors LLC Raises Stock Holdings in CVS Health Corporation $CVS

Lido Advisors LLC boosted its position in CVS Health Corporation (NYSE:CVS) by 44.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 43,133 shares of the pharmacy operator’s stock after acquiring an additional 13,181 shares during the period. Lido Advisors LLC’s holdings in CVS Health were worth $2,975,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of CVS. Avion Wealth increased its holdings in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares during the period. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health in the 2nd quarter worth approximately $30,000. Bell Investment Advisors Inc increased its stake in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the period. Roxbury Financial LLC raised its holdings in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares in the last quarter. Finally, ORG Partners LLC lifted its stake in CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Performance

Shares of CVS opened at $77.61 on Wednesday. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The stock has a market cap of $98.52 billion, a P/E ratio of 204.24, a P/E/G ratio of 0.77 and a beta of 0.48. The business’s 50 day moving average price is $78.73 and its 200-day moving average price is $71.08. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $85.15.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same quarter last year, the company earned $1.09 EPS. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio is 700.00%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CVS shares. Baird R W raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Wells Fargo & Company reduced their price target on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research report on Thursday, November 13th. Truist Financial restated a “buy” rating and issued a $95.00 price objective (up from $92.00) on shares of CVS Health in a report on Thursday, October 30th. Zacks Research lowered CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Finally, Cantor Fitzgerald lifted their price target on CVS Health from $78.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $90.52.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.